Protective effect of hydrogen sulfide is mediated by negative regulation of epigenetic histone acetylation in Parkinson’s disease
Authors:
Open Access
- 17 February 2020
- journal article
- research article
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 16 (1) , 1124-1135
Abstract
Introduction: Derangements in monoaminergic transmission in the substantia nigra with disturbed signaling in the hypothalamic-pituitary-adrenal axis are the major characteristics of Parkinson’s disease (PD). It has been reported that the administration of hydrogen sulfide (H2S) is in practice to treat PD because of its redundant nature in regulating various neuronal signals. Hence, the current investigation was performed to evaluate the hypothesis that H2S might exert protective action via the inhibition of epigenetic histone acetylation.Material and methods: To test this notion, 6-hydroxydopamine (6-OHDA) was used to induce PD and sodium hydrogen sulfide (SHS) was used as a H2S donor and tubastatin A (TSA) was tested in an in vivo rat model to delineate the signaling mechanism.Results: Induction of PD in rats demonstrated elevated oxidative stress with an evidenced decrease in antioxidant enzymes, while elevated pro-inflammatory cytokines and inflammatory mediators were observed in the striatum of PD rats compared to controls. On the other hand, elevated (p < 0.01) levels of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), mRNA transcript of HDAC-2, -3, -4, -6 and total histone deacetylase (HDAC) were found with reduced levels of histone acetyltransferase (HAT) in the brain tissues of PD induced rats.Conclusions: Diversely, H2S exposure reversed these alterations with reduced HDAC activity. Further, PD rats treated with HDAC inhibitor showed a dramatic upsurge in the level of tyrosine hydroxylase, with a decreased level of glial fibrillary acidic protein, -synuclein, tumor necrosis factor , and other cytokines. Thus the results of the study suggest that H2S exerts protection via inhibition of HDAC.Keywords
This publication has 55 references indexed in Scilit:
- HDAC inhibitors and neurodegeneration: At the edge between protection and damagePharmacological Research, 2010
- Hydrogen sulfide, neurogenic inflammation, and cardioprotection: A tale of rotten eggs and vanilloid receptors*Critical Care Medicine, 2010
- Heterogeneous prevalence of recurrent BRCA1 and BRCA2 mutations in Spain according to the geographical area: implications for genetic testingFamilial Cancer, 2009
- Immunohistochemical characterization of subtypes of male breast carcinomaBreast Cancer Research, 2009
- Hydrogen sulphide and its therapeutic potentialNature Reviews Drug Discovery, 2007
- Interleukin-1 and neuronal injuryNature Reviews Immunology, 2005
- Breast carcinoma in menCancer, 2004
- Hydrogen sulfide protects neurons from oxidative stressThe FASEB Journal, 2004
- Hydrogen Sulfide Induces Cyclic AMP and Modulates the NMDA ReceptorBiochemical and Biophysical Research Communications, 2000
- Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's diseaseNeuroscience Letters, 1996